Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
Core Scientific Inc (NASDAQ: CORZ) closed the day trading at $15.55 down -2.75% from the previous closing price of $15.99. In other words, the price has decreased by -$2.75 from its previous closing price. On the day, 12.41 million shares were traded. CORZ stock price reached its highest trading level at $16.15 during the session, while it also had its lowest trading level at $15.53.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Arete on July 22, 2025, initiated with a Buy rating and assigned the stock a target price of $20.
On May 22, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $15. On January 27, 2025, Keefe Bruyette started tracking the stock assigning a Outperform rating and target price of $22.Keefe Bruyette initiated its Outperform rating on January 27, 2025, with a $22 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 25 ’25 when DUCHENE TODD M sold 7,759 shares for $12.39 per share. The transaction valued at 96,142 led to the insider holds 2,049,689 shares of the business.
DUCHENE TODD M bought 7,759 shares of CORZ for $96,142 on Jun 25 ’25. On Jun 06 ’25, another insider, Becker Todd A, who serves as the Former Director of the company, bought 195,687 shares for $12.28 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORZ now has a Market Capitalization of 4883477504 and an Enterprise Value of 5330216448. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.63. Its current Enterprise Value per Revenue stands at 15.298 whereas that against EBITDA is -97.641.
Stock Price History:
The Beta on a monthly basis for CORZ is 6.60, which has changed by 0.39087653 over the last 52 weeks, in comparison to a change of 0.17089343 over the same period for the S&P500. Over the past 52 weeks, CORZ has reached a high of $18.63, while it has fallen to a 52-week low of $6.20. The 50-Day Moving Average of the stock is 10.56%, while the 200-Day Moving Average is calculated to be 26.72%.
Shares Statistics:
Over the past 3-months, CORZ traded about 19.48M shares per day on average, while over the past 10 days, CORZ traded about 13496540 shares per day. A total of 303.15M shares are outstanding, with a floating share count of 284.98M. Insiders hold about 6.69% of the company’s shares, while institutions hold 90.04% stake in the company. Shares short for CORZ as of 1756425600 were 56587006 with a Short Ratio of 2.91, compared to 1753920000 on 57610630. Therefore, it implies a Short% of Shares Outstanding of 56587006 and a Short% of Float of 18.69.
Earnings Estimates
Currently, 1.0 analysts are dedicated to thoroughly evaluating and rating the performance of Core Scientific Inc (CORZ) in the stock market.The consensus estimate for the next quarter is $0.2, with high estimates of $0.2 and low estimates of $0.2.
Analysts are recommending an EPS of between $0.31 and $0.31 for the fiscal current year, implying an average EPS of $0.31. EPS for the following year is $1.76, with 1.0 analysts recommending between $1.76 and $1.76.
Revenue Estimates
7 analysts predict $119.04M in revenue for the current quarter. It ranges from a high estimate of $128.28M to a low estimate of $106M. As of the current estimate, Core Scientific Inc’s year-ago sales were $95.35MFor the next quarter, 7 analysts are estimating revenue of $157.89M. There is a high estimate of $179.06M for the next quarter, whereas the lowest estimate is $144.3M.
A total of 7 analysts have provided revenue estimates for CORZ’s current fiscal year. The highest revenue estimate was $445.86M, while the lowest revenue estimate was $409M, resulting in an average revenue estimate of $425.54M. In the same quarter a year ago, actual revenue was $510.67MBased on 16 analysts’ estimates, the company’s revenue will be $877.93M in the next fiscal year. The high estimate is $1.16B and the low estimate is $515.5M.
